Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “therapy”

782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 782
Index total 30,257
Page 28 / 33

Quick answer

This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

782 results for “therapy” · 30,257 patents in full index Clear search

  1. US 7611693

    Mechanism-based targeted pancreatic beta cell imaging and therapy

    The Board of Regents of the University of Texas System · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  2. US 7582623

    Photoactive metal nitrosyls for blood pressure regulation and cancer therapy

    The Regents of the University of California · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted
  3. US 7579333

    Therapy using a combination of raloxifene and alendronate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 25, 2009 · Expires Aug 20, 2029

    granted
  4. US 7576175

    Alpha-4 beta-1 integrin ligands for imaging and therapy

    The Regents of the University of California · Granted Aug 18, 2009 · Expires Aug 13, 2029

    granted
  5. US 7569673

    Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted
  6. US 7521551

    Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy

    Miravant Pharmaceuticals, Inc. · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted
  7. US 2009062719

    Enhanced PhotoDynamic Therapy with Immune System Assist

    NEUBERGER WOLFGANG [MY] · Granted Mar 5, 2009 · Expires Feb 28, 2029

    granted
  8. US 7494775

    Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer

    UT Board of Regents · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  9. US 7476721

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Jan 13, 2009 · Expires Jan 8, 2029

    granted
  10. US 7470431

    Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer

    The Regents of the University of Colorado · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted
  11. US 7455845

    Use of neurotoxin therapy for treatment of urologic and related disorders related to lowering elevated bladder pressure

    The Regents of the University of Colorado · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted
  12. US 7449557

    Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy

    University of Connecticut Health Center · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted
  13. US 7449192

    Use of neurotoxin therapy for treatment of urologic and related disorders related to neurogenic bladder dysfunction

    The Regents of the University of Colorado · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted
  14. US 7429387

    Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

    The Regents of the University of Colorado · Granted Sep 30, 2008 · Expires Sep 25, 2028

    granted
  15. US 7414039

    Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis

    The Regents of the University of California · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted
  16. US 7374936

    Method and means for site directed therapy

    Actinium Phamaceuticals, Inc. · Granted May 20, 2008 · Expires May 15, 2028

    granted
  17. US 7371364

    Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy

    The Board of Regents of the University of Texas System · Granted May 13, 2008 · Expires May 8, 2028

    granted
  18. US 7338758

    Compositions and methods for the identification, assessment, prevention and therapy of human cancers

    The Board of Regents of the University of Texas System · Granted Mar 4, 2008 · Expires Feb 28, 2028

    granted
  19. US 7326697

    Methods for increasing the therapeutic response to electroconvulsive therapy

    Corcept Therapeutics Incorporated · Granted Feb 5, 2008 · Expires Jan 31, 2028

    granted
  20. US 7314911

    Prostate hyperplasia therapy

    The Board of Regents of the University of Texas System · Granted Jan 1, 2008 · Expires Dec 27, 2027

    granted
  21. US 7312202

    Rationally designed and chemically synthesized promoter for genetic vaccine and gene therapy

    The Board of Regents of the University of Texas System · Granted Dec 25, 2007 · Expires Dec 20, 2027

    granted
  22. US 7309694

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Dec 18, 2007 · Expires Dec 13, 2027

    granted
  23. US 7306914

    Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy

    Odyssey Thera Inc. · Granted Dec 11, 2007 · Expires Dec 6, 2027

    granted
  24. US 7300940

    Integrin α-v β-3 antagonists for use in imaging and therapy

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted